Macrophage Ontogeny and the Extracellular Matrix Contribute to Macrophage Activation in Aged Murine Livers
巨噬细胞个体发育和细胞外基质有助于衰老小鼠肝脏中巨噬细胞的激活
基本信息
- 批准号:9326625
- 负责人:
- 金额:$ 3.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAffectAgingAging-Related ProcessBiochemicalBiological AssayBiologyBiomimeticsBone MarrowCell OntogenyCellsCharacteristicsCollagenDataDimensionsDiseaseElderlyEmbryoEndotoxinsEngineeringEnvironmentExtracellular MatrixFellowshipFibrosisFunctional disorderGlycoproteinsGrowthHepatocyteHomeostasisITGAM geneImmune System DiseasesImmune System and Related DisordersImmune ToleranceImmune responseImmune systemIncidenceIndividualInfectionInfectious AgentInflammagingInflammationInflammatoryInjuryKineticsKupffer CellsLeadLiverMacrophage ActivationMaintenanceMalignant NeoplasmsMechanicsMentorsMentorshipModelingMusMyocardiumNational Research Service AwardsNormal tissue morphologyOrganPhenotypePlayPopulationPropertyRecruitment ActivityRegulationReportingResearchRoleScientistSeveritiesSignal TransductionSourceSurfaceTechniquesTherapeutic InterventionTissuesTrainingUnited StatesWorkage effectage groupage relatedagedcareerchronic liver diseasehealthy agingimplantationin vivoinnovationmacrophagenovel therapeuticsoutcome forecastregenerativerepairedresponsescaffoldtargeted treatmenttherapeutic targetvirtualviscoelasticity
项目摘要
Abstract
The liver is the most regenerative organ in the body following injury or insult, however it is unclear how
some components of the liver, namely the extracellular matrix (ECM) and resident macrophages, interact and
change with aging. Previous work has identified a significant age-related increase in the number and activation
of liver-resident macrophages. Recent studies have also identified the existence of two distinct subsets of
macrophages in the liver: Kupffer cells (embryonic origin) and bone marrow derived macrophages. No study to
date has examined how these two macrophage subsets are affected by the aging process, which may have
major implications for the ability of the host to maintain immune tolerance, as well as respond to infection, injury,
and other chronic liver diseases. We hypothesize that the predominant population of liver macrophages will shift
from embryonic derived to bone marrow derived macrophages in aged murine livers, with major implications for
normal tissue functions. We also hypothesize that changes in the ECM, which composes the macrophage
“niche”, will undergo an increase in stiffness and contribute to macrophage dysfunction with aging. To assess
these hypotheses, we have devised two aims: to 1) examine the role of cell ontogeny on the observed increase
in resident macrophage number and activation in the aged murine liver and 2) characterize the age-related
changes in mechanical and biochemical composition of liver ECM and the effect on the liver-resident
macrophages. Our innovative approach involves a transdisciplinary research and mentoring team including basic
scientists and engineers using advanced models and techniques such as bone marrow chimeric mice, whole
organ decellularization, and biomimetic scaffolds to address our research question. It is critically important to
understand how liver macrophage phenotype and function as well as the liver ECM change during aging, and
the reciprocal regulation between these two tissue components, to devise new therapies to reduce age-related
inflammation and extend healthy aging.
摘要
肝脏是机体损伤或损伤后再生能力最强的器官,但目前尚不清楚如何再生。
肝脏的某些成分,即细胞外基质(ECM)和驻留的巨噬细胞,相互作用,
随着年龄的增长而变化。以前的工作已经确定了一个显着的年龄相关的数量和激活的增加
肝脏巨噬细胞的数量最近的研究还发现存在两个不同的亚群,
肝脏中的巨噬细胞:枯否细胞(胚胎来源)和骨髓来源的巨噬细胞。没有研究,
date已经研究了这两种巨噬细胞亚群如何受到衰老过程的影响,这可能
对宿主维持免疫耐受性以及对感染,损伤,
和其他慢性肝病。我们假设主要的肝巨噬细胞群体将转移
从胚胎来源的巨噬细胞到骨髓来源的巨噬细胞,在老年小鼠肝脏中,
正常组织功能。我们还假设,细胞外基质的变化,
“壁龛”,将经历刚度的增加,并有助于随着衰老的巨噬细胞功能障碍。评估
根据这些假设,我们设计了两个目标:1)检查细胞个体发育对观察到的增加的作用
在老年小鼠肝脏中的常驻巨噬细胞数量和活化方面,以及2)表征年龄相关的
肝脏ECM的机械和生化组成的变化以及对肝脏驻留的影响
巨噬细胞我们的创新方法涉及一个跨学科的研究和指导团队,包括基本的
科学家和工程师使用先进的模型和技术,如骨髓嵌合小鼠,整个
器官去细胞化和仿生支架来解决我们的研究问题。至关重要的是,
了解肝脏巨噬细胞表型和功能以及肝脏ECM在衰老过程中的变化,
这两种组织成分之间的相互调节,以设计新的治疗方法来减少与年龄相关的
炎症和延长健康衰老。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth Stahl其他文献
Elizabeth Stahl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth Stahl', 18)}}的其他基金
Engineering improved delivery and immune profiles of Cas9 orthologues for gene therapy
工程改进了用于基因治疗的 Cas9 直向同源物的递送和免疫特征
- 批准号:
10444901 - 财政年份:2021
- 资助金额:
$ 3.76万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 3.76万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 3.76万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 3.76万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 3.76万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 3.76万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 3.76万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 3.76万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 3.76万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 3.76万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 3.76万 - 项目类别: